Clinical Trial Update: Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing rivaroxaban to warfarin in patients with acute ischemic stroke and atrial fibrillation completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Warfarin (warfarin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Asan Medical Center | Conditions: Ischemic Stroke, Transient Ischemic Attack | Phase 2 | Status: COMPLETED | Results posted: 2017-02-08